Skip Nav Destination
Issues
15 May 2012
-
Cover Image
Cover Image
Methylation of the tumor suppressor gene Ras association domain family 1A (RASSF1A) is an independent adverse prognostic factor in patients with early-stage non–small cell lung carcinoma treated in the phase III trial on perioperative chemotherapy, IFCT-0002. The cover image is a photomicrograph showing RASSF1A protein distribution in immortalized interphasic bronchial epithelial cells, HBEC3, using confocal microscopy. RASSF1A is stained in red (Alexa-fluo red-labeled secondary antibody). Nuclei are shown in light purple (DAPI). For details, see the article by de Fraipont and colleagues on page 2976 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Molecular Pathways
From the Editor
CCR Focus
Perspective
Review
Human Cancer Biology
MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Nelly Burnichon; Alberto Cascón; Francesca Schiavi; Nicole Paes Morales; Iñaki Comino-Méndez; Nasséra Abermil; Lucía Inglada-Pérez; Aguirre A. de Cubas; Laurence Amar; Marta Barontini; Sandra Bernaldo de Quirós; Jérôme Bertherat; Yves-Jean Bignon; Marinus J. Blok; Sara Bobisse; Salud Borrego; Maurizio Castellano; Philippe Chanson; María-Dolores Chiara; Eleonora P.M. Corssmit; Mara Giacchè; Ronald R. de Krijger; Tonino Ercolino; Xavier Girerd; Encarna B. Gómez-García; Álvaro Gómez-Graña; Isabelle Guilhem; Frederik J. Hes; Emiliano Honrado; Esther Korpershoek; Jacques W.M. Lenders; Rocío Letón; Arjen R. Mensenkamp; Anna Merlo; Luigi Mori; Arnaud Murat; Peggy Pierre; Pierre-François Plouin; Tamara Prodanov; Miguel Quesada-Charneco; Nan Qin; Elena Rapizzi; Victoria Raymond; Nicole Reisch; Giovanna Roncador; Macarena Ruiz-Ferrer; Frank Schillo; Alexander P.A. Stegmann; Carlos Suarez; Elisa Taschin; Henri J.L.M. Timmers; Carli M.J. Tops; Miguel Urioste; Felix Beuschlein; Karel Pacak; Massimo Mannelli; Patricia L. M. Dahia; Giuseppe Opocher; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Mercedes Robledo
Molecular Profiling of Pancreatic Neuroendocrine Tumors in Sporadic and Von Hippel-Lindau Patients
Daniela Speisky; Aurélie Duces; Ivan Bièche; Vinciane Rebours; Pascal Hammel; Alain Sauvanet; Stéphane Richard; Pierre Bedossa; Michel Vidaud; Arnaud Murat; Patricia Niccoli; Jean-Yves Scoazec; Philippe Ruszniewski; Anne Couvelard; for the GTE Group (Groupe d'Etude des Tumeurs Endocrines)
Cancer Therapy: Preclinical
L-BLP25 Vaccine plus Letrozole Induces a TH1 Immune Response and Has Additive Antitumor Activity in MUC1-Expressing Mammary Tumors in Mice
Neelima R. Mehta; Gregory T. Wurz; Rebekah A. Burich; Brittany E. Greenberg; Stephen Griffey; Audrey Gutierrez; Katie E. Bell; Jamie L. McCall; Michael Wolf; Michael DeGregorio
Imaging, Diagnosis, Prognosis
Cancer Therapy: Clinical
Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response
Yann Godet; Elizabeth Fabre; Magalie Dosset; Michele Lamuraglia; Emeline Levionnois; Patrice Ravel; Nadine Benhamouda; Aurélie Cazes; Françoise Le Pimpec-Barthes; Beatrice Gaugler; Pierre Langlade-Demoyen; Xavier Pivot; Philippe Saas; Bernard Maillère; Eric Tartour; Christophe Borg; Olivier Adotévi
Pharmacokinetics and Safety of Bortezomib in Patients with Advanced Malignancies and Varying Degrees of Liver Dysfunction: Phase I NCI Organ Dysfunction Working Group Study NCI-6432
Patricia M. LoRusso; Karthik Venkatakrishnan; Ramesh K. Ramanathan; John Sarantopoulos; Daniel Mulkerin; Stephen I. Shibata; Anne Hamilton; Afshin Dowlati; Sridhar Mani; Michelle A. Rudek; Chris H. Takimoto; Rachel Neuwirth; Dixie-Lee Esseltine; Percy Ivy
Predictive Biomarkers and Personalized Medicine
An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial
Florence de Fraipont; Guénaëlle Levallet; Christian Creveuil; Emmanuel Bergot; Michèle Beau-Faller; Mounia Mounawar; Nicolas Richard; Martine Antoine; Isabelle Rouquette; Marie-Christine Favrot; Didier Debieuvre; Denis Braun; Virginie Westeel; Elisabeth Quoix; Elisabeth Brambilla; Pierre Hainaut; Denis Moro-Sibilot; Franck Morin; Bernard Milleron; Gérard Zalcman; on behalf of the Intergroupe Francophone de Cancérologie Thoracique (IFCT)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds